Akanksha Bagchi1, Roy Schwartz2, Philip Hykin2, Sobha Sivaprasad2. 1. NIHR Biomedical Research Centre, Moorfields Eye Hospital, London, UK. akanksha.bagchi@gmail.com. 2. NIHR Biomedical Research Centre, Moorfields Eye Hospital, London, UK.
Abstract
PURPOSE: To develop a diagnostic algorithm in patients with pathologic myopia who present with typical symptoms or signs of myopic choroidal neovascularisation (mCNV). METHODS: Retrospective study. Patients with high myopia and suspected mCNV underwent fluorescein angiography (FFA), structural spectral-domain optical coherence tomography (SD-OCT) and optical coherence tomography angiography (OCTA). Active mCNV on one imaging modality plus clinical features were considered as the benchmark reference for the other two tests. Sensitivity was calculated for each modality individually and in combination. Morphological features were noted on SD-OCT and OCTA. RESULTS: Twenty-seven eyes of 26 patients were analysed. Sensitivity of SD-OCT or FFA alone was 85.19% (23/27 eyes). Sensitivity of OCTA was 74.07% (20/27 eyes). The sensitivity for SD-OCT combined with OCTA was 96.16% and combined with FFA was 97.80%. On OCTA, a "tight net" appearance was seen in 16 eyes (80%); a core vessel was visible in seven eyes (35%), all with active lesions. A "perilesional halo" was visible in 11 eyes (55%) of which 10 had active lesions. CONCLUSION: When combined, OCTA and SD-OCT or SD-OCT and FFA showed similar higher sensitivities than each modality alone. A tight vascular net and the combination of a perilesional halo and a visible core on OCTA may serve as biomarkers of mCNV activity.
PURPOSE: To develop a diagnostic algorithm in patients with pathologic myopia who present with typical symptoms or signs of myopic choroidal neovascularisation (mCNV). METHODS: Retrospective study. Patients with high myopia and suspected mCNV underwent fluorescein angiography (FFA), structural spectral-domain optical coherence tomography (SD-OCT) and optical coherence tomography angiography (OCTA). Active mCNV on one imaging modality plus clinical features were considered as the benchmark reference for the other two tests. Sensitivity was calculated for each modality individually and in combination. Morphological features were noted on SD-OCT and OCTA. RESULTS: Twenty-seven eyes of 26 patients were analysed. Sensitivity of SD-OCT or FFA alone was 85.19% (23/27 eyes). Sensitivity of OCTA was 74.07% (20/27 eyes). The sensitivity for SD-OCT combined with OCTA was 96.16% and combined with FFA was 97.80%. On OCTA, a "tight net" appearance was seen in 16 eyes (80%); a core vessel was visible in seven eyes (35%), all with active lesions. A "perilesional halo" was visible in 11 eyes (55%) of which 10 had active lesions. CONCLUSION: When combined, OCTA and SD-OCT or SD-OCT and FFA showed similar higher sensitivities than each modality alone. A tight vascular net and the combination of a perilesional halo and a visible core on OCTA may serve as biomarkers of mCNV activity.
Authors: Adnan Tufail; Nirodhini Narendran; Praveen J Patel; Sobha Sivaprasad; Winfried Amoaku; Andrew C Browning; Olayinka Osoba; Richard Gale; Sheena George; Andrew J Lotery; Mohammed Majid; Martin McKibbin; Geeta Menon; Christopher Andrews; Christopher Brittain; Aaron Osborne; Yit Yang Journal: Ophthalmology Date: 2013-09 Impact factor: 12.079
Authors: Elsa Bruyère; Alexandra Miere; Salomon Yves Cohen; David Martiano; Anne Sikorav; Andrada Popeanga; Oudy Semoun; Giuseppe Querques; Eric H Souied Journal: Retina Date: 2017-11 Impact factor: 4.256
Authors: K A Kwiterovich; M G Maguire; R P Murphy; A P Schachat; N M Bressler; S B Bressler; S L Fine Journal: Ophthalmology Date: 1991-07 Impact factor: 12.079
Authors: Tien Y Wong; Kyoko Ohno-Matsui; Nicolas Leveziel; Frank G Holz; Timothy Y Lai; Hyeong Gon Yu; Paolo Lanzetta; Youxin Chen; Adnan Tufail Journal: Br J Ophthalmol Date: 2014-07-01 Impact factor: 4.638
Authors: Yong Li; Feihui Zheng; Li Lian Foo; Qiu Ying Wong; Daniel Ting; Quan V Hoang; Rachel Chong; Marcus Ang; Chee Wai Wong Journal: Diagnostics (Basel) Date: 2022-06-08